Adma Biologics Inc (ADMA) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Adma Biologics Inc   (NASDAQ: ADMA)
 

Adma Biologics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Adma Biologics Inc 's inventory turnover ratio sequentially decreased to 0.96 in the first quarter 2026, unsurprisingly, as the Adma Biologics Inc markets continue to deteriorate, and ADMA's faces growing challenges to bring down its inventories. Adma Biologics Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 380 days, from 326 days, in the Dec 31 2025 quarter.

Within Healthcare sector 318 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1497, from total ranking in the fourth quarter 2025 at 1572.

ADMA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Adma Biologics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADMA Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 28.99 % 21.28 % 14.47 % 6.48 % -3.12 %
Y / Y Cost of Sales Growth -37.74 % -7.14 % -3.33 % 10.2 % 26.19 %
Inventory Turnover Ratio (TTM) 0.96 1.12 1.2 1.25 1.25
ADMA's Total Ranking # 1497 # 1572 # 1572 # 787 #
Average inventory processing period 381 325 304 291 293
Seq. Inventory Growth 7.57 % 4.98 % 2.72 % 11.19 % 1.15 %
Seq. Cost of Sales Growth -34.45 % -13.19 % 7.41 % 1.89 % -2.24 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 21
Healthcare Sector # 319
Overall Market # 1497

Inventory Turnover Ratio Statistics
High Average Low
3.59 1.63 0.78
(Dec 31 2014)   (Dec 31 2022)



ADMA Company Profile >> Back to ADMA Efficiency Comparisons >> Compare ADMA Inventory Turnover Ratio to its Competitors

Financial Statements
Adma Biologics Inc 's Inventories $ 222 Millions Visit ADMA's Balance sheet
Adma Biologics Inc 's Cost of Revenues TTM $ 195 Millions Visit ADMA's Income Statement
What are ADMA's Sales? Visit ADMA's Sales by Segment

Other Inventory Turnover Ratios
Adma Biologics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ADMA's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ADMA's Competitors
Inventory Turnover Ratio for ADMA's Suppliers
Inventory Turnover Ratio for ADMA's Customers

You may also want to know
ADMA's Sales Growth Rates ADMA's Pe Price to earnings ratio ADMA's Receivables Turnover Ratio ADMA's Stock Quote
ADMA's Net Income Growth Rates ADMA's Ps Price to Sales ratio ADMA's Sales per Employee ADMA's Asset Turnover Ratio
ADMA's Net Margin ADMA's Pb Price to Book ratio ADMA's Financial Strength Ratios ADMA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
United Therapeutics Corporation  2.41 $ 425.300  Millions$ 177  Millions
Urogen Pharma Ltd   2.38 $ 14.256  Millions$ 6  Millions
Merit Medical Systems Inc  2.37 $ 791.837  Millions$ 334  Millions
Viatris Inc   2.34 $ 9,553.100  Millions$ 4,075  Millions
Perrigo Company Plc  2.34 $ 2,760.400  Millions$ 1,178  Millions
Caredx Inc   2.34 $ 64.029  Millions$ 27  Millions
Amgen Inc   2.33 $ 14,781.000  Millions$ 6,335  Millions
Angiodynamics Inc   2.32 $ 142.000  Millions$ 61  Millions
Neuroone Medical Technologies Corp  2.31 $ 4.423  Millions$ 2  Millions
China Pharma Holdings Inc  2.29 $ 3.698  Millions$ 2  Millions
Cytosorbents Corporation  2.29 $ 10.000  Millions$ 4  Millions
Vivos Inc  2.27 $ 0.136  Millions$ 0  Millions
Beta Bionics Inc   2.26 $ 47.000  Millions$ 21  Millions
Resmed Inc   2.26 $ 2,094.000  Millions$ 927  Millions
Apyx Medical Corp  2.26 $ 20.000  Millions$ 9  Millions
Tela Bio Inc   2.25 $ 26.000  Millions$ 12  Millions
Eton Pharmaceuticals Inc   2.21 $ 39.000  Millions$ 18  Millions
Johnson and Johnson  2.20 $ 31,005.000  Millions$ 14,083  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.19 $ 11.133  Millions$ 5  Millions
Icu Medical Inc  2.18 $ 1,338.223  Millions$ 615  Millions
Zomedica Corp   2.18 $ 12.298  Millions$ 6  Millions
Bio techne Corp  2.17 $ 424.000  Millions$ 196  Millions
Repligen Corp  2.16 $ 359.567  Millions$ 166  Millions
Embecta Corp   2.15 $ 398.000  Millions$ 185  Millions
Boston Scientific Corporation  2.15 $ 6,358.000  Millions$ 2,961  Millions
Ultragenyx Pharmaceutical Inc   2.15 $ 110.338  Millions$ 51  Millions
Yunhong Green Cti Ltd   2.14 $ 18.000  Millions$ 8  Millions
Inspiremd Inc   2.14 $ 7.000  Millions$ 3  Millions
Phibro Animal Health Corporation  2.13 $ 1,010.688  Millions$ 475  Millions
Accuray Incorporated  2.11 $ 313.685  Millions$ 149  Millions

Date modified: 2026-06-22T14:32:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.